US 8685932
Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 8685932 (Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases) held by OPTION PHARMACEUTICALS, LLC expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OPTION PHARMACEUTICALS, LLC
- Grant date
- Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P, A61P29/00